|
Volumn 25, Issue 1, 2014, Pages 5-7
|
Clinical and ethical implications of mitochondrial gene transfer
|
Author keywords
Assisted reproductive technologies; mtDNA mutations
|
Indexed keywords
EXTRACHROMOSOMAL DNA;
MITOCHONDRIAL DNA;
RIBOSOME RNA;
TRANSFER RNA;
BLASTOCYST;
CELL RESPIRATION;
CHROMOSOME ABERRATION;
CONTROLLED CLINICAL TRIAL (TOPIC);
CYTOPLASM;
EMBRYONIC STEM CELL;
ENERGY YIELD;
ETHICS;
GENE TRANSFER;
GENETIC DISORDER;
GERM LINE GENE THERAPY;
HAPLOTYPE;
HETEROPLASMY;
HUMAN;
MEIOTIC SPINDLE;
METAPHASE CHROMOSOME;
MITOCHONDRIAL GENE;
MITOCHONDRIAL GENE DISORDER;
MITOCHONDRIAL GENOME;
NONHUMAN;
NOTE;
OOCYTE;
OXIDATIVE PHOSPHORYLATION;
POINT MUTATION;
POSTNATAL GROWTH;
PRIORITY JOURNAL;
UNITED KINGDOM;
ZYGOTE;
ASSISTED REPRODUCTIVE TECHNOLOGIES;
MTDNA MUTATIONS;
DNA, MITOCHONDRIAL;
FEMALE;
GENES, MITOCHONDRIAL;
GENETIC THERAPY;
GREAT BRITAIN;
HUMANS;
MALE;
MITOCHONDRIA;
MITOCHONDRIAL DISEASES;
MUTATION;
NUCLEAR TRANSFER TECHNIQUES;
OOCYTES;
REPRODUCTIVE TECHNIQUES, ASSISTED;
UNITED STATES;
|
EID: 84890939116
PISSN: 10432760
EISSN: 18793061
Source Type: Journal
DOI: 10.1016/j.tem.2013.09.001 Document Type: Note |
Times cited : (52)
|
References (8)
|